Industry Growth Insights published a new data on “Autacoids and Related Drugs Market”. The research report is titled “Autacoids and Related Drugs Market research by Types (Polypeptides, Decarboxylated Amino Acids, Eicosanoids), By Applications (Allergies, Inflammation, Gastric Acid Secretion, Neuroendocrine Regulation, Chronic Pain, Cardiovascular Diseases, Gastrointestinal Diseases), By Players/Companies Bedford Laboratories, Bristol-Myers Squibb, Fresenius, Abbott Laboratories, Sanofi, AstraZeneca, Bedford Laboratories”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Autacoids and Related Drugs Market Research Report
By Type
Polypeptides, Decarboxylated Amino Acids, Eicosanoids
By Application
Allergies, Inflammation, Gastric Acid Secretion, Neuroendocrine Regulation, Chronic Pain, Cardiovascular Diseases, Gastrointestinal Diseases
By Companies
Bedford Laboratories, Bristol-Myers Squibb, Fresenius, Abbott Laboratories, Sanofi, AstraZeneca, Bedford Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Autacoids and Related Drugs Market Report Segments:
The global Autacoids and Related Drugs market is segmented on the basis of:
Types
Polypeptides, Decarboxylated Amino Acids, Eicosanoids
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergies, Inflammation, Gastric Acid Secretion, Neuroendocrine Regulation, Chronic Pain, Cardiovascular Diseases, Gastrointestinal Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bedford Laboratories
- Bristol-Myers Squibb
- Fresenius
- Abbott Laboratories
- Sanofi
- AstraZeneca
- Bedford Laboratories
Highlights of The Autacoids and Related Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polypeptides
- Decarboxylated Amino Acids
- Eicosanoids
- By Application:
- Allergies
- Inflammation
- Gastric Acid Secretion
- Neuroendocrine Regulation
- Chronic Pain
- Cardiovascular Diseases
- Gastrointestinal Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autacoids and Related Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autacoids are chemicals that act on the autonomic nervous system, which controls involuntary functions such as heart rate, digestion, and blood pressure. Autacoids can be endogenous (produced within the body) or exogenous (derived from outside sources). Related drugs include beta blockers (such as propranolol), calcium channel blockers (such as nifedipine), and angiotensin converting enzyme inhibitors (ACE inhibitors).
Some of the major companies in the autacoids and related drugs market are Bedford Laboratories, Bristol-Myers Squibb, Fresenius, Abbott Laboratories, Sanofi, AstraZeneca, Bedford Laboratories.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autacoids and Related Drugs Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Autacoids and Related Drugs Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Autacoids and Related Drugs Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Autacoids and Related Drugs Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Autacoids and Related Drugs Market Size & Forecast, 2020-2028 4.5.1 Autacoids and Related Drugs Market Size and Y-o-Y Growth 4.5.2 Autacoids and Related Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polypeptides
5.2.2 Decarboxylated Amino Acids
5.2.3 Eicosanoids
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Allergies
6.2.2 Inflammation
6.2.3 Gastric Acid Secretion
6.2.4 Neuroendocrine Regulation
6.2.5 Chronic Pain
6.2.6 Cardiovascular Diseases
6.2.7 Gastrointestinal Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autacoids and Related Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autacoids and Related Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polypeptides
9.6.2 Decarboxylated Amino Acids
9.6.3 Eicosanoids
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Allergies
9.10.2 Inflammation
9.10.3 Gastric Acid Secretion
9.10.4 Neuroendocrine Regulation
9.10.5 Chronic Pain
9.10.6 Cardiovascular Diseases
9.10.7 Gastrointestinal Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polypeptides
10.6.2 Decarboxylated Amino Acids
10.6.3 Eicosanoids
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Allergies
10.10.2 Inflammation
10.10.3 Gastric Acid Secretion
10.10.4 Neuroendocrine Regulation
10.10.5 Chronic Pain
10.10.6 Cardiovascular Diseases
10.10.7 Gastrointestinal Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polypeptides
11.6.2 Decarboxylated Amino Acids
11.6.3 Eicosanoids
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Allergies
11.10.2 Inflammation
11.10.3 Gastric Acid Secretion
11.10.4 Neuroendocrine Regulation
11.10.5 Chronic Pain
11.10.6 Cardiovascular Diseases
11.10.7 Gastrointestinal Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polypeptides
12.6.2 Decarboxylated Amino Acids
12.6.3 Eicosanoids
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Allergies
12.10.2 Inflammation
12.10.3 Gastric Acid Secretion
12.10.4 Neuroendocrine Regulation
12.10.5 Chronic Pain
12.10.6 Cardiovascular Diseases
12.10.7 Gastrointestinal Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polypeptides
13.6.2 Decarboxylated Amino Acids
13.6.3 Eicosanoids
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Allergies
13.10.2 Inflammation
13.10.3 Gastric Acid Secretion
13.10.4 Neuroendocrine Regulation
13.10.5 Chronic Pain
13.10.6 Cardiovascular Diseases
13.10.7 Gastrointestinal Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autacoids and Related Drugs Market: Competitive Dashboard
14.2 Global Autacoids and Related Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bedford Laboratories
14.3.2 Bristol-Myers Squibb
14.3.3 Fresenius
14.3.4 Abbott Laboratories
14.3.5 Sanofi
14.3.6 AstraZeneca
14.3.7 Bedford Laboratories